STESteris

Health care · Medical Devices · NYSE

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 10-K, Item 1

Headquarters: Dublin, L2
CEO: Daniel A. Carestio
Next results: around Feb 3, 2027

Compare with peers → Embed

RevenueFY2017–26 $5.9B+8.7% Highest in 10 years 10-K FY2026 · XBRL Net incomeFY2017–26 $782.3M+27.3% Highest in 10 years 10-K FY2026 · XBRL Free cash flowFY2017–26 $972.4M+25.0% Highest in 10 years 10-K FY2026 · XBRL Operating marginFY2017–26 18.6%+2.7 pts 8.7% in FY2017 10-K FY2026 · XBRL

What changed

10-K filed May 29, 2026 against May 29, 2025

Area	What changed	Source
Risk factors	10 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	11 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	5 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed May 29, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-05-29. Quoted as filed.

The introduction and evolution of climate- and sustainability-related laws, regulations and reporting requirements—many of which are not uniform across jurisdictions—can increase the complexity and cost of compliance and heighten our exposure to enforcement actions, litigation and reputational harm. For example, the European Union…
10-K, Item 1A

All 10 new paragraphs →

Accounting checks

latest 10-K

11 of 11 clear 0 worth a look. Checks, not verdicts.

✓
Receivables +4.7% vs revenue +8.7% (-4.1 pts)
✓
Cash from operations $1.3B vs net income $782.3M (FY ending 2026-03-31)
✓
Inventory +8.7% vs revenue +8.7% (-0.0 pts)
✓
Same auditor in both 10-Ks: Ernst & Young LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Description of Uncertain Tax Positions
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 6, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · Under this shelf registration process, we may from time to time sell the following securities in one or more offerings at prices and on other terms to be determined at the time of offering: • senior unsecured debt securities of STERIS plc or STERIS Irish FinCo Unlimited Company (“debt securities”),
Nov 5, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Nov 4, 20268-K Quarterly results, Restructuring or exit costs 8-K items 2.02, 2.05
Nov 4, 20268-K Material agreement signed, Material agreement ended, New debt or obligation 8-K items 1.01, 1.02, 2.03
Oct 13, 20268-K Material agreement signed 8-K item 1.01

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on STE in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/STE/export.csv") into a cell.